PIERIS PHARMACEUTICALS INC shareholders Q3 2023

PIERIS PHARMACEUTICALS INC's ticker is PIRS and the CUSIP is 720795103. A total of 45 filers reported holding PIERIS PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.07 and the average weighting 0.1%.

PIERIS PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Lynx1 Capital Management LP 9,775,849$2,913,2031.93%
Aquilo Capital Management, LLC 3,303,190$984,3510.89%
CM Management, LLC 649,400$193,5210.20%
BVF INC/IL 20,609,863$6,141,7390.17%
WEALTH EFFECTS LLC 11,700$3,4870.00%
NJ State Employees Deferred Compensation Plan 30,000$8,9400.00%
HUDSON VALLEY INVESTMENT ADVISORS INC /ADV 14,000$4,1720.00%
ACADIAN ASSET MANAGEMENT LLC 962,358$2860.00%
TWO SIGMA ADVISERS, LP 24,400$7,2710.00%
Tower View Wealth Management LLC 1,000$00.00%
Truvestments Capital LLC 1,120$3340.00%
Tower Research Capital LLC (TRC) 30,904$9,2090.00%
Cutler Group LLC / CA 4,500$10.00%
JPMORGAN CHASE & CO 112,285$33,4610.00%
Renaissance Technologies 381,291$1140.00%
BARCLAYS PLC 5,006$10.00%
ROYAL BANK OF CANADA 3,136$1,0000.00%
COMMERCE BANK 20,000$5,9600.00%
Allworth Financial LP 350$1050.00%
VANGUARD GROUP INC 1,035,540$308,5910.00%
External links

This page lists PIERIS PHARMACEUTICALS INC's shareholders in Q3 2023. To view PIERIS PHARMACEUTICALS INC's shareholder history, click here.